The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome
A 7-year-old white boy with the long QT syndrome began to experience recurrent syncope associated with torsade de pointes ventricular tachycardia in spite of beta-blocker therapy. The patient was therefore given a combined alphaand beta-blocking agent (labetalol) with complete suppression of the syn...
Gespeichert in:
| Veröffentlicht in: | Chest 1991-12, Vol.100 (6), p.1724-1725 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1725 |
|---|---|
| container_issue | 6 |
| container_start_page | 1724 |
| container_title | Chest |
| container_volume | 100 |
| creator | Grubb, Blair P. |
| description | A 7-year-old white boy with the long QT syndrome began to experience recurrent syncope associated with torsade de pointes ventricular tachycardia in spite of beta-blocker therapy. The patient was therefore given a combined alphaand beta-blocking agent (labetalol) with complete suppression of the syncopal episodes. This suggests a role for combined alpha- and beta-blocking agents in the therapy of arrhythmias associated with the long QT syndrome. |
| doi_str_mv | 10.1378/chest.100.6.1724 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72503888</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369216528220</els_id><sourcerecordid>72503888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-6da3770718072ac4b32535588c3d2fab1799ebcfb3426a1780fa11f9609877863</originalsourceid><addsrcrecordid>eNp1kM1rFDEYh4Moda3evQg5iLdZ8zGTZLwtRa2wUMTt1ZDJvNNJyUxqkrXsf292Z6l48BRefl_hQegtJWvKpfpoR0h5TQlZizWVrH6GVrTltOJNzZ-jFSGUVVy07CV6ldI9KTdtxQW6oG3T1oyt0M_dCPg2AQ4DvonG463pIBsfPHYzzkXcRTB5gjkfLZsYx0MeJ2cS3qQUrDMZevzo8ngyb8N8h7_v8I_D3McwwWv0YjA-wZvze4luv3zeXV1X25uv364228rWtMmV6A2XkkiqiGTG1h1nDW8apSzv2WA6KtsWOjt0vGbCUKnIYCgdWkFaJaUS_BJ9WHofYvi1L0z05JIF780MYZ-0ZA3hSqliJIvRxpBShEE_RDeZeNCU6CNSfUJaLqKFPiItkXfn7n03Qf83sDAs-vuzbpI1fohmti492RoqG3GqOS-P7m58dBF0moz3pZQvm_dhH2fj_1n-tESgoPvtIOpkHcwW-hK3WffB_f_bfwA7VqMZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72503888</pqid></control><display><type>article</type><title>The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Grubb, Blair P.</creator><creatorcontrib>Grubb, Blair P.</creatorcontrib><description>A 7-year-old white boy with the long QT syndrome began to experience recurrent syncope associated with torsade de pointes ventricular tachycardia in spite of beta-blocker therapy. The patient was therefore given a combined alphaand beta-blocking agent (labetalol) with complete suppression of the syncopal episodes. This suggests a role for combined alpha- and beta-blocking agents in the therapy of arrhythmias associated with the long QT syndrome.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.100.6.1724</identifier><identifier>PMID: 1959422</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Administration, Oral ; Antiarythmic agents ; Biological and medical sciences ; Cardiovascular system ; Child ; Electrocardiography ; Humans ; Labetalol - administration & dosage ; Long QT Syndrome - complications ; Long QT Syndrome - drug therapy ; Long QT Syndrome - physiopathology ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Syncope - etiology ; Torsades de Pointes - complications ; Torsades de Pointes - drug therapy</subject><ispartof>Chest, 1991-12, Vol.100 (6), p.1724-1725</ispartof><rights>1991 The American College of Chest Physicians</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-6da3770718072ac4b32535588c3d2fab1799ebcfb3426a1780fa11f9609877863</citedby><cites>FETCH-LOGICAL-c415t-6da3770718072ac4b32535588c3d2fab1799ebcfb3426a1780fa11f9609877863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5175624$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1959422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grubb, Blair P.</creatorcontrib><title>The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome</title><title>Chest</title><addtitle>Chest</addtitle><description>A 7-year-old white boy with the long QT syndrome began to experience recurrent syncope associated with torsade de pointes ventricular tachycardia in spite of beta-blocker therapy. The patient was therefore given a combined alphaand beta-blocking agent (labetalol) with complete suppression of the syncopal episodes. This suggests a role for combined alpha- and beta-blocking agents in the therapy of arrhythmias associated with the long QT syndrome.</description><subject>Administration, Oral</subject><subject>Antiarythmic agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Child</subject><subject>Electrocardiography</subject><subject>Humans</subject><subject>Labetalol - administration & dosage</subject><subject>Long QT Syndrome - complications</subject><subject>Long QT Syndrome - drug therapy</subject><subject>Long QT Syndrome - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Syncope - etiology</subject><subject>Torsades de Pointes - complications</subject><subject>Torsades de Pointes - drug therapy</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1rFDEYh4Moda3evQg5iLdZ8zGTZLwtRa2wUMTt1ZDJvNNJyUxqkrXsf292Z6l48BRefl_hQegtJWvKpfpoR0h5TQlZizWVrH6GVrTltOJNzZ-jFSGUVVy07CV6ldI9KTdtxQW6oG3T1oyt0M_dCPg2AQ4DvonG463pIBsfPHYzzkXcRTB5gjkfLZsYx0MeJ2cS3qQUrDMZevzo8ngyb8N8h7_v8I_D3McwwWv0YjA-wZvze4luv3zeXV1X25uv364228rWtMmV6A2XkkiqiGTG1h1nDW8apSzv2WA6KtsWOjt0vGbCUKnIYCgdWkFaJaUS_BJ9WHofYvi1L0z05JIF780MYZ-0ZA3hSqliJIvRxpBShEE_RDeZeNCU6CNSfUJaLqKFPiItkXfn7n03Qf83sDAs-vuzbpI1fohmti492RoqG3GqOS-P7m58dBF0moz3pZQvm_dhH2fj_1n-tESgoPvtIOpkHcwW-hK3WffB_f_bfwA7VqMZ</recordid><startdate>19911201</startdate><enddate>19911201</enddate><creator>Grubb, Blair P.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19911201</creationdate><title>The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome</title><author>Grubb, Blair P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-6da3770718072ac4b32535588c3d2fab1799ebcfb3426a1780fa11f9609877863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Administration, Oral</topic><topic>Antiarythmic agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Child</topic><topic>Electrocardiography</topic><topic>Humans</topic><topic>Labetalol - administration & dosage</topic><topic>Long QT Syndrome - complications</topic><topic>Long QT Syndrome - drug therapy</topic><topic>Long QT Syndrome - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Syncope - etiology</topic><topic>Torsades de Pointes - complications</topic><topic>Torsades de Pointes - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grubb, Blair P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grubb, Blair P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>1991-12-01</date><risdate>1991</risdate><volume>100</volume><issue>6</issue><spage>1724</spage><epage>1725</epage><pages>1724-1725</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>A 7-year-old white boy with the long QT syndrome began to experience recurrent syncope associated with torsade de pointes ventricular tachycardia in spite of beta-blocker therapy. The patient was therefore given a combined alphaand beta-blocking agent (labetalol) with complete suppression of the syncopal episodes. This suggests a role for combined alpha- and beta-blocking agents in the therapy of arrhythmias associated with the long QT syndrome.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>1959422</pmid><doi>10.1378/chest.100.6.1724</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-3692 |
| ispartof | Chest, 1991-12, Vol.100 (6), p.1724-1725 |
| issn | 0012-3692 1931-3543 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72503888 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Administration, Oral Antiarythmic agents Biological and medical sciences Cardiovascular system Child Electrocardiography Humans Labetalol - administration & dosage Long QT Syndrome - complications Long QT Syndrome - drug therapy Long QT Syndrome - physiopathology Male Medical sciences Pharmacology. Drug treatments Syncope - etiology Torsades de Pointes - complications Torsades de Pointes - drug therapy |
| title | The Use of Oral Labetalol in the Treatment of Arrhythmias Associated with the Long QT Syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T07%3A45%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Use%20of%20Oral%20Labetalol%20in%20the%20Treatment%20of%20Arrhythmias%20Associated%20with%20the%20Long%20QT%20Syndrome&rft.jtitle=Chest&rft.au=Grubb,%20Blair%20P.&rft.date=1991-12-01&rft.volume=100&rft.issue=6&rft.spage=1724&rft.epage=1725&rft.pages=1724-1725&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.100.6.1724&rft_dat=%3Cproquest_cross%3E72503888%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72503888&rft_id=info:pmid/1959422&rft_els_id=S0012369216528220&rfr_iscdi=true |